Edward Lazarus

Eddie Lazarus serves as the Chief Legal Officer at Sonos. He leads the company’s legal, corporate governance, SEC reporting, government affairs, regulatory and compliance activities.

Eddie comes to Sonos after a distinguished career as an attorney, including most recently as General Counsel and Chief Strategy Officer for Tribune Media Company from 2013 to 2019. Lazarus served as the Chief of Staff to the Chairman of the Federal Communications Commission (FCC) from June 2009 to Feb. 2012. At the FCC, he oversaw policy development and implementation, strategic planning, communications, legislative and intergovernmental affairs, and agency management. Before working at the FCC, Eddie was a partner and member of the Management Committee at the law firm Akin Gump Strauss Hauer & Feld, where he chaired the firm’s national litigation steering committee. Prior to entering private practice, Eddie served as a federal prosecutor in Los Angeles.

In addition to his career as an attorney, Eddie is the author of two highly acclaimed books: “Black Hills/White Justice: The Sioux Nation Versus the United States, 1775 to the Present” and “Closed Chambers: The Rise, Fall, and Future of the Modern Supreme Court.”

When AI Helps Generate Inventions, Who Is the Inventor?

By Andrei Iancu and Rama Elluru This commentary from the CSIS-SCSP Task Force on IP in the AI Era was originally published in the Special Competitive Studies Project’s Substack on February 15, 2024. With roots in the U.S. constitution, patent rights provide an exclusive property right in new inventions like drugs,
Read More

Standard Essential Patents and European Economic Security

By Kirti Gupta and Chris Borges On April 27, 2023, the European Commission published a draft proposal on standard essential patents (SEPs) seeking to address the perceived lack of transparency and predictability in the licensing of SEPs. The commission proposes the creation of a competence center within the European Union Intellectual
Read More

Proposed Federal Use of March-in Rights Would Weaken American Innovation

By Sujai Shivakumar and Thomas Howell   The Biden administration is considering exercising something called “march-in rights” as a policy prescription to curb drug prices. But as with any prescription, there is a need to weigh efficacy against the side-effects. In this case, there is evidence that the vast majority of
Read More